Growth Metrics

Merit Medical Systems (MMSI) Cost of Revenue (2016 - 2025)

Merit Medical Systems (MMSI) has disclosed Cost of Revenue for 16 consecutive years, with $198.6 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 9.01% to $198.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $777.6 million through Dec 2025, up 9.04% year-over-year, with the annual reading at $777.6 million for FY2025, 9.04% up from the prior year.
  • Cost of Revenue hit $198.6 million in Q4 2025 for Merit Medical Systems, roughly flat from $197.7 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $198.6 million in Q4 2025 to a low of $137.0 million in Q1 2021.
  • Historically, Cost of Revenue has averaged $169.3 million across 5 years, with a median of $169.5 million in 2023.
  • Biggest YoY gain for Cost of Revenue was 16.42% in 2021; the steepest drop was 1.95% in 2021.
  • Year by year, Cost of Revenue stood at $149.7 million in 2021, then increased by 6.13% to $158.9 million in 2022, then grew by 9.52% to $174.0 million in 2023, then increased by 4.71% to $182.2 million in 2024, then increased by 9.01% to $198.6 million in 2025.
  • Business Quant data shows Cost of Revenue for MMSI at $198.6 million in Q4 2025, $197.7 million in Q3 2025, and $198.0 million in Q2 2025.